A Study Assessing KB407 for the Treatment of Cystic Fibrosis

NCT05504837 · clinicaltrials.gov ↗
PHASE1
Phase
RECRUITING
Status
20
Enrollment
INDUSTRY
Sponsor class

Conditions

Interventions

Sponsor

Krystal Biotech, Inc.